| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.34 | 3e-06 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.31 | 5e-06 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.14 | 8e-06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.2 | 1e-05 |